• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人健康促进的经济评估——方法学问题与挑战

Economic evaluation of health promotion for older people-methodological problems and challenges.

作者信息

Huter Kai, Kocot Ewa, Kissimova-Skarbek Katarzyna, Dubas-Jakóbczyk Katarzyna, Rothgang Heinz

机构信息

SOCIUM - Research Center on Inequality and Social Policy, University of Bremen, Mary-Somerville-Straße 5, 28359, Bremen, Germany.

High-profile area Health Sciences, University of Bremen, Bremen, Germany.

出版信息

BMC Health Serv Res. 2016 Sep 5;16 Suppl 5(Suppl 5):328. doi: 10.1186/s12913-016-1519-y.

DOI:10.1186/s12913-016-1519-y
PMID:27609155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5016726/
Abstract

BACKGROUND

The support of health promotion activities for older people gains societal relevance in terms of enhancing the health and well-being of older people with a view to the efficient use of financial resources in the healthcare sector. Health economic evaluations have become an important instrument to support decision-making processes in many countries. Sound evidence on the cost-effectiveness of health promotion activities would encourage support for the implementation of health promotion activities for older people. This debate article discusses to what extent economic evaluation techniques are appropriate to support decision makers in the allocation of resources regarding health promotion activities for older people. We address the problem that the economic evaluation of these interventions is hampered by methodological obstacles that limit comparability, e.g. with economic evaluations of curative measures. Our central objective is to describe and discuss the specific problems and challenges entailed in the economic evaluation of health promotion activities especially for older people with regard to their usefulness for informing decision making processes.

DISCUSSION

Beyond general problems concerning the economic evaluation of health promotion, our discussion focusses on problems that pertain to the analysis of cost and outcomes of health promotion interventions for older people. With regard to costs these are general problems of economic evaluations, namely the actual implementation of a societal perspective, the appropriate measurement and valuation of informal caregiver time, the measurement and valuation of productivity costs and costs incurred in added years of life. The main problems concerning the identification and measurement of outcomes are related to the identification of outcome parameters that, firstly, adequately reflect the broad effects of health promotion interventions, especially social benefits that gain importance for older people, and secondly, ensure a comparability of effects across different age groups. In particular, the limitations of the widely used QALY for older people are discussed and recently developed alternatives are presented.

CONCLUSIONS

The key conclusion of the article is that a comparison of the effects of different health promotion initiatives between different age groups by means of economic evaluation is not recommendable. Taking into account the complex outcomes of health promotion interventions it has to be accepted that the outcomes of these interventions will often not be comparable with clinical interventions and have to be assessed differently.

摘要

背景

从提高老年人健康水平和福祉的角度出发,以有效利用医疗保健部门的财政资源为目的,对老年人健康促进活动的支持具有社会意义。健康经济评估已成为许多国家支持决策过程的重要工具。关于健康促进活动成本效益的可靠证据将鼓励支持开展老年人健康促进活动。这篇辩论文章讨论了经济评估技术在多大程度上适合支持决策者在老年人健康促进活动资源分配方面的决策。我们探讨了这样一个问题,即这些干预措施的经济评估受到方法学障碍的阻碍,这些障碍限制了可比性,例如与治疗措施的经济评估相比。我们的核心目标是描述和讨论健康促进活动经济评估中所涉及的具体问题和挑战,特别是对于老年人而言,这些问题和挑战对于为决策过程提供信息的有用性。

讨论

除了健康促进经济评估的一般问题外,我们的讨论重点关注与老年人健康促进干预措施成本和结果分析相关的问题。关于成本,这些是经济评估的一般问题,即社会视角的实际应用、非正式照护者时间的适当测量和估值、生产力成本的测量和估值以及增加生命年所产生的成本。关于结果识别和测量的主要问题与结果参数的识别有关,首先,这些参数要充分反映健康促进干预措施的广泛影响,特别是对老年人来说变得重要的社会效益,其次,要确保不同年龄组之间效果的可比性。特别是,讨论了广泛使用的质量调整生命年对老年人的局限性,并介绍了最近开发的替代方法。

结论

本文的关键结论是,不建议通过经济评估对不同年龄组之间不同健康促进举措的效果进行比较。考虑到健康促进干预措施的复杂结果,必须承认这些干预措施的结果往往与临床干预措施不可比,必须进行不同的评估。

相似文献

1
Economic evaluation of health promotion for older people-methodological problems and challenges.老年人健康促进的经济评估——方法学问题与挑战
BMC Health Serv Res. 2016 Sep 5;16 Suppl 5(Suppl 5):328. doi: 10.1186/s12913-016-1519-y.
2
Economic evaluation of health promotion interventions for older people: do applied economic studies meet the methodological challenges?老年人健康促进干预措施的经济评估:应用经济学研究是否应对了方法学挑战?
Cost Eff Resour Alloc. 2018 Apr 16;16:14. doi: 10.1186/s12962-018-0100-4. eCollection 2018.
3
The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.基于家庭的、由护士主导的老年人健康促进的临床效果和成本效益:系统评价。
Health Technol Assess. 2012;16(20):1-72. doi: 10.3310/hta16200.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Economic evaluation of health promotion and primary prevention actions for older people-a systematic review.老年人健康促进和初级预防措施的经济评价——系统评价。
Eur J Public Health. 2017 Aug 1;27(4):670-679. doi: 10.1093/eurpub/ckx030.
6
Value for money in the health sector: the contribution of primary health care.卫生部门的性价比:初级卫生保健的贡献。
Health Policy Plan. 1987 Jun;2(2):107-28. doi: 10.1093/heapol/2.2.107.
7
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
8
Generalisability in economic evaluation studies in healthcare: a review and case studies.医疗保健经济评估研究中的可推广性:综述与案例研究
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. doi: 10.3310/hta8490.
9
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.吸烟及降低吸烟率的经济影响:证据综述
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.
10
Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders预防和治疗精神、神经及物质使用障碍的干预措施、政策和平台的成本效益及可负担性

引用本文的文献

1
Incorporating frailty to address the key challenges to geriatric economic evaluation.将虚弱纳入考虑,以应对老年经济学评估的关键挑战。
BMC Geriatr. 2024 Feb 14;24(1):155. doi: 10.1186/s12877-024-04752-5.
2
Outcome domains measured in randomized controlled trials of physical activity for older adults: a rapid review.随机对照试验中测量老年人身体活动的结局指标:快速综述。
Int J Behav Nutr Phys Act. 2023 Mar 24;20(1):34. doi: 10.1186/s12966-023-01431-3.
3
Alternatives to the quality-adjusted life year: How well do they address common criticisms?替代质量调整生命年的指标:它们在多大程度上解决了常见的批评?
Health Serv Res. 2023 Apr;58(2):433-444. doi: 10.1111/1475-6773.14116. Epub 2022 Dec 28.
4
Systematic review and critical methodological appraisal of community-based falls prevention economic models.基于社区的跌倒预防经济模型的系统评价与关键方法学评估
Cost Eff Resour Alloc. 2022 Jul 16;20(1):33. doi: 10.1186/s12962-022-00367-y.
5
Economic evaluation of community-based falls prevention interventions for older populations: a systematic methodological overview of systematic reviews.基于社区的老年人跌倒预防干预措施的经济评价:系统评价的系统方法学综述。
BMC Health Serv Res. 2022 Mar 26;22(1):401. doi: 10.1186/s12913-022-07764-2.
6
Projecting the long-term societal value of a disease-modifying treatment for Alzheimer's disease in the United States.预测美国阿尔茨海默病疾病修正治疗的长期社会效益。
Alzheimers Dement. 2022 Jan;18(1):142-151. doi: 10.1002/alz.12578. Epub 2022 Feb 9.
7
The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review.质量调整生命年(QALY)测量在评估健康干预措施对老年人群影响中的应用:一项系统的范围综述。
Arch Public Health. 2021 Nov 18;79(1):201. doi: 10.1186/s13690-021-00729-7.
8
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.评价纳入照料者和社会因素的模拟模型中阿尔茨海默病药物治疗的成本效益
JAMA Netw Open. 2021 Oct 1;4(10):e2129392. doi: 10.1001/jamanetworkopen.2021.29392.
9
The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT).三种阿尔茨海默病预防策略的成本效益:来自多领域阿尔茨海默病预防试验(MAPT)的结果。
J Prev Alzheimers Dis. 2021;8(4):425-435. doi: 10.14283/jpad.2021.47.
10
The need to incorporate the impact of population ageing into the post-COVID-19 policy and planning reset in Low and Middle Income Countries.需要将人口老龄化的影响纳入新冠肺炎疫情后的政策和规划调整,在中低收入国家。
Glob Health Action. 2021 Jan 1;14(1):1921351. doi: 10.1080/16549716.2021.1921351.

本文引用的文献

1
Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?使用ICECAP-O和EQ-5D评估综合护理对体弱老年人的成本效益:评估工具的选择重要吗?
Eur J Health Econ. 2015 May;16(4):437-50. doi: 10.1007/s10198-014-0583-7. Epub 2014 Apr 24.
2
Quality of life of nursing home residents with dementia: validation of the German version of the ICECAP-O.痴呆症养老院居民的生活质量:德国版ICECAP-O的验证
PLoS One. 2014 Mar 14;9(3):e92016. doi: 10.1371/journal.pone.0092016. eCollection 2014.
3
Quality of life instruments for economic evaluations in health and social care for older people: a systematic review.用于老年人健康和社会护理经济评估的生活质量工具:系统评价。
Soc Sci Med. 2014 Feb;102:83-93. doi: 10.1016/j.socscimed.2013.11.050. Epub 2013 Dec 4.
4
How to estimate productivity costs in economic evaluations.如何在经济评估中估算生产力成本。
Pharmacoeconomics. 2014 Apr;32(4):335-44. doi: 10.1007/s40273-014-0132-3.
5
Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues.公共卫生经济学:对公共卫生干预措施经济评估指南的系统综述及关键方法学问题探讨
BMC Public Health. 2013 Oct 24;13:1001. doi: 10.1186/1471-2458-13-1001.
6
Productivity costs in economic evaluations: past, present, future.经济评估中的生产力成本:过去、现在、未来。
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
7
A validation of the ICECAP-O in a population of post-hospitalized older people in the Netherlands.荷兰住院后老年人群体中 ICECAP-O 的验证。
Health Qual Life Outcomes. 2013 Apr 8;11:57. doi: 10.1186/1477-7525-11-57.
8
The inclusion of informal care in applied economic evaluation: a review.将非正规护理纳入应用经济评估:综述。
Value Health. 2012 Sep-Oct;15(6):975-81. doi: 10.1016/j.jval.2012.05.009.
9
Measuring and valuing quality of life for public health research: application of the ICECAP-O capability index in the Australian general population.测量和评估公共卫生研究中的生活质量:澳大利亚普通人群中 ICECAP-O 能力指数的应用。
Int J Public Health. 2013 Jun;58(3):367-76. doi: 10.1007/s00038-012-0407-4. Epub 2012 Sep 8.
10
A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?在防跌倒临床环境中,ICECAP-O 与 EQ-5D 的比较:它们是互补还是替代?
Qual Life Res. 2013 Jun;22(5):969-77. doi: 10.1007/s11136-012-0225-4. Epub 2012 Jun 22.